Synthetic derivatives of osthole for the prevention of hepatitis

Medicinal Chemistry

Volumn 3, Issue 1, 2007, Pages 35-44

  Okamoto, Toshihiro ^a   Kobayashi, Tadashi ^a   Yoshida, Shinichi ^a  

^a Nippon Chemiphar Co Ltd   (Japan)

Author keywords

Allyloxycoumarin; Apoptosis; Nitrocoumarin; Nitroquinoline; Osthole skeleton

Indexed keywords

2 AMINOSUCCINIC ACID [8 (3 METHYL 2 BUTENYL)COUMARIN 7 YL] ESTER; 3 (7 METHOXY 8 PROPYLQUINOLINOL 3 YL)ACRYLIC ACID ETHYL ESTER; 3 AMINO 7 METHOXY 8 PROPYLQUINOLINE; 5 ALLYLOXY 7 (PYRIDINE 4 YL METHOXY)COUMARIN; 5,7 BISALLYLOXYCOUMARIN; 6 ALLYL 7 METHOXY 4 METHYL 8 NITROCOUMARIN; 7 CARBOXYEMTHYLOXY 8 (3 METHYL 2 BUTENYL)COUMARIN; 7 ETHOXY 8 (3 METHYL 2 BUTENYL)COUMARIN; 7 METHOXY 1 METHYL 8 (3 METHYLBUTYL) 1,2,3,4 TETRAHYDROQUINOLINE; 7 METHOXY 8 (3 METHYL 2 BUTENYL)QUINOLINE; 7 METHOXY 8 (3 METHYLBUTYL) 1,2,3,4 TETRAHYDROQUINOLINE; 7 METHOXY 8 (3 METHYLBUTYL) 1H QUINOLIN 2 ONE; 7 METHOXY 8 PROPYL 1H QUINOLINE 2 ONE; 7 METHOXY 8 PROPYLQUINOLINE; 8 (3 METHYL 2 BUTENYL) 7 (3 METHYL 2 BUTENYLOXY)COUMARIN; 8 (3 METHYL 2 BUTENYL) 7 (4 NITROPHENOXY)COUMARIN; 8 (3 METHYL 2 BUTENYL) 7 (NITROBENZYLOXY)COUMARIN; 8 (3 METHYL 2 BUTENYL) 7 (PYRIDINE 4 YL METHOXY)COUMARIN; 8 (3 METHYL 2 BUTENYL)COUMARIN; 8 ALLYL 7 BENZYLOXY 3 NITROQUINOLINE; 8 ALLYL 7 METHOXY 3 NITROQUINOLINE; 8 ALLYL 7 METHOXY 4 METHYL 6 NITROCOUMARIN; 8 ALLYL 7 METHOXYQUINOLINE; 8 ALLYLOXY 5 NITROQUINOLINE; ALANINE AMINOTRANSFERASE; CONCANAVALIN A; COUMARIN DERIVATIVE; N (7 METHOXY 8 PROPYLQUINOLIN 3 YL)BENZAMIDE; OSTHOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HEPATITIS; INHIBITION KINETICS; LIVER PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; CONCANAVALIN A; COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FEMALE; HEPATITIS, TOXIC; INDICATORS AND REAGENTS; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

EID: 33846073130     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340607779317607     Document Type: Article

References (28)

1. Karabay, O.; Tamer, A.; Tahtaci, M.; Vardi, S.; Celebi, H. J. Microbiol. Immunol. Infect., 2005, 38, 262.
2. Sarin, S.K.; Kumar, M.; Kumar, R.; Kazim, S.N.; Guptan, R.C.; Sakhuja, P.; Sharma, B.C. Am. J. Gastroenterol., 2005, 100, 2463.
3. Henry, M.J. N. Eng. J. Med., 2005, 353, 1182.
4. Macias, J.; Japon, M.A.; Saez, C.; Palacios, R.B.; Mira, J.A.; Garcia-Garcia, J.A.; Merchante, N.; Vergara, S.; Lozano, F.; Gomez-Mateos, J.; Pineda, J.A. J. Infect Dis., 2005, 192, 1566.
5. Mita, A.; Hashikura, Y.; Tagawa, Y.; Nakayama, J.; Kawakubo, M.; Miyagawa, S. Am. J. Gastroenterol., 2005, 100, 2551.
6. Zhang, S.J.; Chen, H.Y.; Chen, Z.X.; Wang, X.Z. World J. Gastroenterol., 2005, 11, 4351.
7. Okamoto, T.; Hino, O. Recent Res. Devel. Cancer, 2000, 3, 275.
8. Okamoto, T.; Kajino, K.; Hino, O. Jpn. J. Pharmacol., 2001, 87, 177.
9. Hoult J.R.; Paya, M. Gen. Pharmacol., 1996, 27, 713.
10. Suzuki, H. Dictionary in Kampo Medicine: Ishiyaku Pub. 1994.
11. Teng, C.MLin, C.H.; Ko, F.N.; Wu, T.S.; Huang, T.F. Naunyn Schmiedebergs Arch. Pharmacol., 1994, 349, 202.
12. Matsuda, H.; Tomohiro, N.; Ido, Y.; Kubo, M. Biol. Pharm. Bull., 2002, 25, 809.
13. Ko, F.N.; Wu, T.S.; Liou, M.J.; Huang, T.F.; Teng, C.M. Thromb. Haemost., 1989, 62, 996.
14. Guh, J.H.; Yu, S.M.; Ko, F.N.; Wu, T.S.; Teng, C.M. Eur. J. Pharmacol., 1996, 298, 191.
15. Huang, R.L.; Chen, C.C.; Huang, Y.L.; Hsieh, D.J.; Hu, C.P.; Chen, C.F.; Chang, C. Hepatology, 1996, 24, 508.
16. Wu, S.N.; Lo, Y.K.; Chen, C.C.; Li, H.F.; Chiang, H.T. Biochem. Pharmacol., 2002, 63, 199.
17. Lee, Y.Y.; Lee, S.; Jin, J.L.; Yun-Choi, H.S. Arch. Pharm. Res., 2003, 26, 723.
18. Yamahara, J.; Kozuka, M.; Sawada, T.; Fujimura, H.; Nakano, K.; Tomimatsu, T.; Nohara, T. Chem. Pharm. Bull., 1985, 33, 1676.
19. Ko, F.N.; Wu, T.S.; Liou, M.J.; Huang, T.F.; Teng, C.M. Eur. J. Pharmacol., 1992, 219, 29.
20. Li, X.X.; Hara, I.; Matsumiya, T. Biol. Pharm. Bull., 2002, 25, 738.
21. Okamoto, T.; Yoshida, Y.; Kobayashi, T.; Okabe, S. Jpn. J. Pharmacol., 2001, 85, 95.
22. Okamoto, T.; Kawasaki, T.; Hino. O. Biochem. Pharmacol., 2003, 65, 677.
23. Okamoto, T.; Kobayashi, T.; Yoshida, Y. Curr. Med. Chem-Anti-Cancer Agents, 2005, 5, 47.
24. Tiegs, G.; Hentshel, J.; Wendel, A. J. Clin. Invest., 1992, 90, 196.
25. Gantner, F.; Leist, MLohse, A.W.; Germann, P.G.; Tiegs, G. Hepatology, 1995, 21, 190.
26. Zhou, F.; Ajuebor, M.N.; Beck, P.L.; Le, T.; Hogaboam, C.M.; Swain, M.G. Hepatology, 2005, 42, 372.
27. Okamoto, T.; Nakano, Y.; Yamakawa, T.; Kara, K.; Yamamura, Ken-Ichi.; Hino, O. Jpn. J. Pharmacol., 1999, 79, 289.
28. Okamoto, T.; Furuya, M.; Yamakawa, T.; Yamamura, K-I.; Hino, O. Biochem. Biophys. Res. Commun., 1996, 226, 762.